A novel approach to positron emission tomography in lung cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18805196.
- Also identified by DOI 10.1016/j.athoracsur.2008.03.072.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
18F-fluorodeoxyglucose positron emission tomography-computed tomography is integral to the staging of lung cancer. We describe the combined use of diagnostic preoperative 18F-fluorodeoxyglucose positron emission tomography-computed tomography, intraoperative 18F-fluorodeoxyglucose handheld gamma probe detection, and immediate postoperative 18F-fluorodeoxyglucose positron emission tomography-computed tomography patient and specimen imaging for improved staging and determination of adequacy of mediastinal lymph node dissection.
Medical subject headings
- Fluorodeoxyglucose F18
- Lung Neoplasms
- Lymph Nodes
- Positron-Emission Tomography